Europe Neurorehabilitation Devices Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Neurorehabilitation Devices Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Neurorehabilitation Devices Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Neurorehabilitation Devices Market Regional Analysis

6.2 Europe Neurorehabilitation Devices Market Revenue 2021-2031 (US$ Million)

6.3 Europe Neurorehabilitation Devices Market Forecast Analysis

7. Europe Neurorehabilitation Devices Market Analysis – by Product Type

7.1 Neurorobotic System

7.1.1 Overview
7.1.2 Neurorobotic System: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Brain Computer Interface

7.2.1 Overview
7.2.2 Brain Computer Interface: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Non-invasive Stimulators

7.3.1 Overview
7.3.2 Non-invasive Stimulators: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Wearable Devices

7.4.1 Overview
7.4.2 Wearable Devices: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Neurorehabilitation Devices Market Analysis – by Application

8.1 Stroke

8.1.1 Overview
8.1.2 Stroke: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Traumatic Brain Injury

8.2.1 Overview
8.2.2 Traumatic Brain Injury: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Spinal Cord Injury

8.3.1 Overview
8.3.2 Spinal Cord Injury: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Parkinson\'s Disease

8.4.1 Overview
8.4.2 Parkinson\'s Disease: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Cerebral Palsy

8.5.1 Overview
8.5.2 Cerebral Palsy: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Neurorehabilitation Devices Market Analysis – by End User

9.1 Rehabilitation Centers

9.1.1 Overview
9.1.2 Rehabilitation Centers: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Hospitals and Clinics

9.2.1 Overview
9.2.2 Hospitals and Clinics: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Home Care

9.3.1 Overview
9.3.2 Home Care: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Neurorehabilitation Devices Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Neurorehabilitation Devices Market Breakdown, by Key Country, 2024 and 2031 (%)
10.2.1.1 Europe Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.1.1 UK: Europe Neurorehabilitation Devices Market Breakdown, by Product Type
10.2.1.1.2 UK: Europe Neurorehabilitation Devices Market Breakdown, by Application
10.2.1.1.3 UK: Europe Neurorehabilitation Devices Market Breakdown, by End User

10.2.1.2 Germany: Europe Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.2.1 Germany: Europe Neurorehabilitation Devices Market Breakdown, by Product Type
10.2.1.2.2 Germany: Europe Neurorehabilitation Devices Market Breakdown, by Application
10.2.1.2.3 Germany: Europe Neurorehabilitation Devices Market Breakdown, by End User

10.2.1.3 France: Europe Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.3.1 France: Europe Neurorehabilitation Devices Market Breakdown, by Product Type
10.2.1.3.2 France: Europe Neurorehabilitation Devices Market Breakdown, by Application
10.2.1.3.3 France: Europe Neurorehabilitation Devices Market Breakdown, by End User

10.2.1.4 Russia: Europe Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.4.1 Russia: Europe Neurorehabilitation Devices Market Breakdown, by Product Type
10.2.1.4.2 Russia: Europe Neurorehabilitation Devices Market Breakdown, by Application
10.2.1.4.3 Russia: Europe Neurorehabilitation Devices Market Breakdown, by End User

10.2.1.5 Italy: Europe Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.5.1 Italy: Europe Neurorehabilitation Devices Market Breakdown, by Product Type
10.2.1.5.2 Italy: Europe Neurorehabilitation Devices Market Breakdown, by Application
10.2.1.5.3 Italy: Europe Neurorehabilitation Devices Market Breakdown, by End User

10.2.1.6 Rest of Europe: Europe Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Neurorehabilitation Devices Market Breakdown, by Product Type
10.2.1.6.2 Rest of Europe: Europe Neurorehabilitation Devices Market Breakdown, by Application
10.2.1.6.3 Rest of Europe: Europe Neurorehabilitation Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 BIONIK

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 BioXtreme Ltd

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Blackrock Microsystems Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Ekso Bionics Holdings Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 EMOTIV

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Hocoma AG

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Medtronic Plc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Renishaw Plc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Tyromotion GmbH

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Neurorehabilitation Devices Market